Davenport & Co’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-58,147
Closed -$1.32M 1189
2024
Q4
$1.32M Buy
58,147
+862
+2% +$18.7K 0.01% 578
2024
Q3
$1.22M Buy
57,285
+12,422
+28% +$244K 0.01% 595
2024
Q2
$856K Sell
44,863
-842
-2% -$17.2K 0.01% 654
2024
Q1
$881K Buy
+45,705
New +$906K 0.01% 646
2022
Q3
Sell
-14,793
Closed -$369K 1005
2022
Q2
$369K Sell
14,793
-1,228
-8% -$36.7K ﹤0.01% 761
2022
Q1
$540K Buy
16,021
+3,587
+29% +$118K ﹤0.01% 718
2021
Q4
$404K Buy
12,434
+386
+3% +$12.7K ﹤0.01% 812
2021
Q3
$421K Buy
12,048
+318
+3% +$12.4K ﹤0.01% 758
2021
Q2
$488K Buy
+11,730
New +$469K ﹤0.01% 651

Other funds holding FMS

Davenport & Co's FMS Position: Q1 2025 in Review

Davenport & Co sold out of Fresenius Medical Care (FMS) in Q1 2025, closing a stake of 58,147 shares — an estimated $1.32M sold.

Davenport & Co first reported a position in FMS in Q2 2021 and held it in 9 quarters. The position peaked at $1.32M in Q4 2024. 201 funds tracked by Wall St. Rank hold FMS as of Q1 2025.

  • Davenport & Co reported no remaining Fresenius Medical Care position as of Q1 2025 after selling out during the quarter.
  • Davenport & Co sold 58,147 Fresenius Medical Care shares in Q1 2025, an estimated $1.32M.
  • Davenport & Co first reported a position in Fresenius Medical Care in Q2 2021 and held it in 9 quarters.
  • Davenport & Co's Fresenius Medical Care position peaked at $1.32M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2025.

Based on Davenport & Co's 13F filing for Q1 2025, filed 28 Apr 2025.